Haitao Xu
Anqing, 246000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in newly diagnosed and relapsed/refractory acute myeloid leukemia: results of a single center study.
Journal: Annals of hematology
Published: December 12, 2024
ARF6 Promotes AML Progression via Activation of PI3K/AKT/mTOR Signaling.
Journal: Cancer medicine
Published: December 07, 2024
LST1 expression correlates with immune infiltration and predicts poor prognosis in acute myeloid leukemia.
Journal: Discover oncology
Published: November 11, 2024
High expression of ARHGEF5 predicts unfavorable prognosis in acute myeloid leukemia.
Journal: Discover oncology
Published: May 28, 2024
A commentary on 'Iron replacement therapy in iron deficiency anemia: a perspective revisited for low-and middle-income countries'.
Journal: International journal of surgery (London, England)
Published: November 03, 2023
Doxorubicin-loaded PEG-CdTe QDs conjugated with anti-CXCR4 mAbs: a novel delivery system for extramedullary multiple myeloma treatment.
Journal: Journal of materials science. Materials in medicine
Published: June 14, 2023
Reduced CXCR4 expression in associated with extramedullary and predicts poor survival in newly diagnosed multiple myeloma.
Journal: Expert review of hematology
Published: August 15, 2022
Pan-Cancer Analysis Reveals the Relation between TRMT112 and Tumor Microenvironment.
Journal: Journal of oncology
Published: May 21, 2022
Analysis of Pan-Cancer Revealed the Immunological and Prognostic Potential of CBX3 in Human Tumors.
Journal: Frontiers in medicine
Published: February 05, 2022
Primary testicular lymphoma: A SEER analysis of 1,169 cases.
Journal: Oncology letters
Published: March 15, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026